Merck KGaA
Ariel bought Merck KGaA on the view that biopharma spending is recovering after inventory destocking and funding constraints. The inflection is most visible in Process Solutions…
MRK.DE
4 published ideas on Merck KGaA across 4 funds — 4 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Merck KGaA: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Ariel bought Merck KGaA on the view that biopharma spending is recovering after inventory destocking and funding constraints. The inflection is most visible in Process Solutions…
First Eagle highlighted strong sales for the cancer drug Keytruda during the quarter. The company also announced an agreement to acquire Bio-Techne. Investors responded…
Merck is a relatively recent purchase whose Life Science division returned to growth, expanding by more than 8% in the March quarter. The fund sees green shoots in research…
Ariel bought Merck KGaA because it believes a recovery in biopharma spending is underway after a prolonged period of destocking and funding constraints. The most important…